Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

NCT06889454 · clinicaltrials.gov ↗

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

PCOS
Hyperinsulinism
Hyperandrogenism
Metabolic Syndrome

Interventions

DRUG: GLP-1 receptor agonist
DRUG: Oral contraceptive
DRUG: Metformin
OTHER: Lifestyle modification

Sponsor

Attikon Hospital